CPT 2006 gives new injection codes and allows E/Ms, but payers, prostate cancer drugs still a concern

Why This Topic Matters

These CPT 2006 changes affect how practices report common medication administration services and how they coordinate billing across payers. The article is especially relevant for groups managing prostate cancer therapies, infusion services, and the shift from legacy Medicare G-codes to CPT codes.

Article Sections

1. CPT 2006 drug administration updates

   Introduces the upcoming CPT 2006 changes for injection and infusion reporting and notes the timing of implementation. Summarizes the general scope of the new drug-administration code families.

2. Evaluation and management services and modifier -25

   Discusses the relationship between separately reportable evaluation and management services and the new injection coding structure. Addresses payer attention and broader reimbursement concerns.

3. Included services for hydration, therapeutic, prophylactic, and diagnostic injections and infusion services

   Describes the types of services bundled into the new hydration and infusion section of CPT. Covers general reporting considerations for administration services and related supplies.

4. Injection coding transition and chemotherapy

   Reviews the transition from earlier injection and chemotherapy administration codes to the CPT 2006 structure. Focuses on how the article frames chemotherapy-related administration for prostate cancer therapy and related distinctions.

5. Category III codes

   Notes two newly released Category III procedure codes and their place in the 2006 update cycle. Includes a brief discussion of implementation timing and related reporting context.